These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. For debate: that Australia should consider changing to the bivalent vaccine. Stern PL. Sex Health; 2010 Sep; 7(3):238-41. PubMed ID: 21058497 [No Abstract] [Full Text] [Related]
3. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 2007 Mar 23; 56(RR-2):1-24. PubMed ID: 17380109 [Abstract] [Full Text] [Related]
4. [Diseases caused by human papilloma viruses]. Zollner U, Schwarz TF. Dtsch Med Wochenschr; 2011 May 23; 136(20):1067-72. PubMed ID: 21560109 [Abstract] [Full Text] [Related]
5. [Cytology and DNA HPV-testing in the era of HPV-vaccine]. Spaczyński M, Malkowska-Walczak B, Nowak-Markwitz E. Ginekol Pol; 2007 Sep 23; 78(9):696-700. PubMed ID: 18159823 [Abstract] [Full Text] [Related]
6. [The first vaccine for prevention of cervix cancer and other human papillomavirus related diseases gets a positive evaluation by the European Drug Authority]. Kinderkrankenschwester; 2006 Sep 23; 25(9):389-90. PubMed ID: 17017592 [No Abstract] [Full Text] [Related]
11. Cervical cancer vaccine development. Frazer IH. Sex Health; 2010 Sep 23; 7(3):230-4. PubMed ID: 20719210 [Abstract] [Full Text] [Related]
12. HPV vaccination--more answers, more questions. Sawaya GF, Smith-McCune K. N Engl J Med; 2007 May 10; 356(19):1991-3. PubMed ID: 17494933 [No Abstract] [Full Text] [Related]
13. An update on barriers to adolescent human papillomavirus vaccination in the USA. Berenson AB. Expert Rev Vaccines; 2015 May 10; 14(10):1377-84. PubMed ID: 26292763 [Abstract] [Full Text] [Related]
14. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM, Barr E, Haupt RM. J Natl Cancer Inst; 2010 Mar 03; 102(5):325-39. PubMed ID: 20139221 [Abstract] [Full Text] [Related]
15. Commentary on opinion pieces re Australian human papillomavirus vaccine policy. McIntyre P. Sex Health; 2010 Sep 03; 7(3):242-3. PubMed ID: 21058498 [No Abstract] [Full Text] [Related]
16. Preventing cervical cancer and genital warts - How much protection is enough for HPV vaccines? Stanley M. J Infect; 2016 Jul 05; 72 Suppl():S23-8. PubMed ID: 27211079 [Abstract] [Full Text] [Related]
17. Reducing the health burden of HPV infection through vaccination. Soper D. Infect Dis Obstet Gynecol; 2006 Jul 05; 2006 Suppl():83084. PubMed ID: 16967913 [Abstract] [Full Text] [Related]
18. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Villa LL, Costa RL, Petta CA, Andrade RP, Paavonen J, Iversen OE, Olsson SE, Høye J, Steinwall M, Riis-Johannessen G, Andersson-Ellstrom A, Elfgren K, Krogh Gv, Lehtinen M, Malm C, Tamms GM, Giacoletti K, Lupinacci L, Railkar R, Taddeo FJ, Bryan J, Esser MT, Sings HL, Saah AJ, Barr E. Br J Cancer; 2006 Dec 04; 95(11):1459-66. PubMed ID: 17117182 [Abstract] [Full Text] [Related]
20. Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil(®)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts. McCormack PL. Drugs; 2014 Jul 04; 74(11):1253-83. PubMed ID: 25022951 [Abstract] [Full Text] [Related] Page: [Next] [New Search]